Centene Corporation

NYSE:CNC

Medical - Healthcare Plans

Healthcare
$67.45 +1.10%

+$0.67 today

Market cap
$33.39B
Beta
1.09
P/E (TTM)
-4.7
EPS (TTM)
-$13.09
52W Low $25.08High $66.55

Volume 6.29M

Average 6.16M

CNC Common Stock Repurchased

Cash spent buying back the company's own shares.

Centene CorporationNYSE: CNC

Common Stock Repurchased · Q2 FY2026 · quarter ended Jun 2026

Common stock repurchased declines year over year

Q2 FY2026 common stock repurchased of $4M (cash outflow) fell 99.1% year over year, in line with the -98.7% change in trailing-twelve-month common stock repurchased. Sequentially, it fell 86.2% from the prior quarter. Over 3 fiscal years it compounded at -46.5% a year.

Context

  • Common stock repurchased amounted to 0.2% of revenue in FY2025, down 1.7 pp from a year earlier.
  • Common stock repurchased grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -99.1% toward the trailing-twelve-month pace of -98.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$4M-86.2% QoQ
Last fiscal yearDec 2025
-$475M-84.8% YoY
LTMJun 2026
-$35M-98.7% YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-99.1%——
1 year-84.8%——
3-year CAGR-46.5%——
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2025
(475M) USD
Year-over-year change
+84.8%

Common Stock Repurchased vs competitors

How CNC compares with its peers on the latest reported figures

  • CNC's LTM Jun 2026 common stock repurchased of $35M is the 5th largest of the 9 companies compared; the peer median is $83M.
  • Its year-over-year change of -98.7% is the 5th highest of 7, against a peer median of -56.1%.
  • Common stock repurchased amounts to 0.0% of revenue for CNC, versus a peer median of 0.1%.
CNC Competitors Peer median
Common Stock Repurchased for CNC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UNHUnitedHealth Group IncorporatedLTM Sep 2026$9.77B +69.2%-7.5%2.2%
ELVElevance Health Inc.LTM Sep 2026$2.16B -45.3%+4.0%1.1%
CICigna CorporationLTM Sep 2026$1.53B -67.0%-21.9%0.5%
HUMHumana Inc.LTM Sep 2026$152M -3.8%-58.4%0.1%
CNCCentene CorporationLTM Jun 2026$35M -98.7%-46.5%0.0%
MOHMolina Healthcare, Inc.LTM Sep 2026$14M -99.1%+35.7%0.0%
CVSCVS Health CorporationLTM Jun 2026$0 -100.0%—0.0%
OSCROscar Health, Inc.LTM Jun 2026$0 ——0.0%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding CNC) $83M-56.1%-7.5%0.1%

Competitors are the stored peer set for CNC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.34B1.2B2.7B3.29B(6.68B)
Depreciation & Amortization1.48B1.55B1.29B1.24B1.28B
Deferred Income Tax(132M)(631M)(78M)13M(60M)
Stock-Based Compensation203M234M216M212M204M
Change in Working Capital1.38B2.19B3.37B(4.52B)823M
Accounts Receivables(2.45B)(1.63B)(2.38B)(4.33B)1.48B
Inventory(1.14B)02.12B00
Accounts Payables1.14B421M3.4B(528M)(657M)
Other Working Capital3.83B3.4B234M346M0
Other Non-Cash Items(54M)1.71B546M(91M)9.52B
Operating Cash Flow4.21B6.26B8.05B154M5.09B
Capital Expenditures(910M)(1B)(799M)(644M)(767M)
Acquisitions (Net)(466M)1.02B619M990M(19M)
Purchases of Investments(7.4B)(6.74B)(6.62B)(7.18B)(4.54B)
Sales of Investments5.46B3.8B5.52B5.79B5.78B
Other Investing Activities19M0000
Investing Cash Flow(3.3B)(2.92B)(1.28B)(1.05B)453M
Debt Repayment1.76B(1.13B)19M678M(1.15B)
Common Stock Issued070M44M46M37M
Common Stock Repurchased(297M)(3.1B)(1.63B)(3.12B)(475M)
Dividends Paid00000
Other Financing Activities(102M)(41M)0(6M)(19M)
Financing Cash Flow1.36B(4.2B)(1.57B)(2.41B)(1.6B)
Effect of Forex Changes50M(187M)(85M)174M(114M)
Net Change in Cash2.32B(1.04B)5.12B(3.13B)3.83B
Free Cash Flow3.3B5.26B7.25B(490M)4.32B

Centene Corporation

NYSE:CNC

Intrinsic Alpha fair value

Locked

Current Price

$67.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.